ASML Lifts Guidance Again as UBS Sees Room for Upgrades — But Vietnam Shows the Order Book Isn't Automatic
Published on 10/27/2026 at 09:10 | Editorial boerse-global.de
ASML has raised its full-year outlook for the third time this year, guiding 2026 revenue to EUR 44–45 billion at a gross margin of roughly 56%. The driver is familiar: the breakneck build-out of AI infrastructure keeps pulling demand for leading-edge chipmaking equipment. Yet the more telling signal for shareholders may not be the top line at all, but how much profit ASML can wring from that demand — and how much of the surrounding enthusiasm is already priced in.
UBS expects consensus earnings-per-share estimates for 2027 and 2028 to rise by 5–10% following the quarterly figures, and the bank reaffirmed its emphatic "Conviction Buy" rating. In the analysts' reading, results broadly matched what professional investors had anticipated, while operating profit came in ahead of consensus. That distinction matters: numbers can be largely expected and still leave headroom for higher forward estimates.
By UBS's reckoning, EBIT ran about 5% above the market consensus, and the midpoint of the fourth-quarter EBIT guidance topped the corresponding consensus figure by roughly 7%. The upbeat stance therefore rests on both the quarter just closed and the outlook ahead. It is, however, a forecast: the estimate revisions UBS predicts have not yet been reported as actual business results.
Price Targets Tell a Less Uniform Story
Not every analyst has responded by lifting target prices. Some houses raised their marks, while others trimmed theirs. That need not contradict the improved operating outlook. An earnings estimate and a price target answer different questions — one concerns expected business performance, the other the valuation derived from it. The recent round of changes, in short, does not add up to a uniform re-rating to the upside.
Should investors sell immediately? Or is it worth buying ASML Holding?
The economic backdrop comes from the third quarter of 2026, when ASML posted net sales of EUR 11.662 billion and net profit of EUR 4.960 billion, at a gross margin of 57.5%. For the current fourth quarter, management has guided revenue to a range of EUR 14.2 billion to EUR 15.2 billion.
Surging AI demand should not be mistaken for a broad recovery across the semiconductor market. According to ASML, weaker business in chips for consumer electronics and cars continues to hold back investment outside the AI segment, leaving growth unevenly distributed across the industry.
China Exposure Adds a Political Layer
Export policy gives the picture an extra dimension. China accounted for 23% of system sales in the third quarter, up from 14% in the prior period, keeping the prospect of further export restrictions squarely on the risk list.
Alongside that, the gap between announced industrial projects and signed contracts has been on display. Reuters reported yesterday that Vietnam is likely to miss its target for test production at its first semiconductor plant in 2027, and that an agreement to purchase equipment from ASML has not yet been reached. For investors, the distinction is worth keeping: expansion plans on paper and contracted business are not the same thing.
The report concerns one specific project. It evidences neither a cancellation at ASML nor a general softening of demand — but without a completed purchase agreement, no secured revenue contribution can be derived from the Vietnamese venture either.
ASML Holding at a turning point? This analysis reveals what investors need to know now.
Capacity Still Runs Behind Demand
Set against that is what ASML's management said roughly two weeks ago: planned delivery capacity for 2027 and 2028 will not fully cover customer demand, and the company is therefore examining a further capacity expansion for 2028. The two statements can coexist. A single fab project may slip behind schedule while demand from other customers exceeds available capacity. For now, the Vietnam news points to project-specific risk rather than a turnaround in the trend reported by management.
A second example of diverging project trajectories came from Elon Musk just over a week ago. According to Bloomberg, he said ASML and other suppliers had accelerated deliveries of equipment for the Terafab project of Tesla and SpaceX, naming the third or fourth quarter of 2028 as the target for chip production in large volumes.
Reported figures remain the firmer yardstick for assessing the business than individual fab plans. Those results describe business already booked, whereas expectations for the months ahead remain forecasts and should be kept separate from them. Having raised its full-year revenue guidance about two weeks ago, management is betting on further growth despite uneven progress at individual customer projects. The decisive question is less whether every announced plant keeps to its original timetable than whether ASML can convert the aggregate demand it expects into shipments and sales.
Ad
ASML Holding Stock: New Analysis - 27 October
Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
